Hongmei Xu

4PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)MechanobiologyMolecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 04, 2024
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors.

Babar Bashir, Judy S Wang, Gerald Falchook

|Dec 13, 2023
Bioanalysis of the Bicycle® toxin conjugate BT5528 and released monomethyl auristatin E via liquid chromatography-tandem mass spectrometry.

Joseph A Tweed, Fern Adams-Dam, Jane Allanson

|Apr 30, 2021
Pharmacokinetics of Selinexor: The First-in-Class Selective Inhibitor of Nuclear Export.

Justin C Bader, Albiruni R Abdul Razak, Sharon Shacham

|Mar 26, 2021
Selinexor population pharmacokinetic and exposure-response analyses to support dose optimization in patients with diffuse large B-cell lymphoma.

Hongmei Xu, Hanbin Li, Russ Wada

Pageof 1

Frequent Collaborators

2 joint publications

Gavin Bennett

1 joint publications

Joseph A Tweed

1 joint publications

Fern Adams-Dam

1 joint publications

Jane Allanson